| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_FNDC3B_0021900 | Exon-Exon | chr3:172025153-172025291 | chr3:172307363-172307501 | 139 nt | 0.5396 |
| hsa_FNDC3B_0022000 | Exon-Exon | chr3:172025153-172046866 | chr3:172307363-172329076 | 318 nt | 0.5063 |
| hsa_FNDC3B_0022100 | Exon-Exon | chr3:172025153-172059021 | chr3:172307363-172341231 | 910 nt | 0.4890 |
| hsa_FNDC3B_0022200 | Exon-Exon | chr3:172025153-172064230 | chr3:172307363-172346440 | 1303 nt | 0.5019 |
| hsa_FNDC3B_0022300 | Exon-Exon | chr3:172025153-172098883 | chr3:172307363-172381093 | 2242 nt | 0.4946 |
| hsa_FNDC3B_0023300 | Exon-Exon | chr3:172046742-172062048 | chr3:172328952-172344258 | 996 nt | 0.5040 |
| hsa_FNDC3B_0024300 | Exon-Exon | chr3:172050879-172064230 | chr3:172333089-172346440 | 810 nt | 0.5012 |
| hsa_FNDC3B_0024600 | Exon-Exon | chr3:172052734-172062048 | chr3:172334944-172344258 | 609 nt | 0.5255 |
| hsa_FNDC3B_0024700 | Exon-Exon | chr3:172052734-172070873 | chr3:172334944-172353083 | 1154 nt | 0.5139 |
| hsa_FNDC3B_0025000 | Exon-Exon | chr3:172058903-172118492 | chr3:172341113-172400702 | 250 nt | 0.3080 |
A study in mice demonstrated that the circFNDC3B was significantly downregulated in hearts post-myocardial infarction and in human cardiac tissues of ischemic cardiomyopathy patients, where its overexpression in cardiac endothelial cells increased vascular endothelial growth factor expression, enhanced angiogenic activity, and reduced apoptosis [Tian et al. DOI:10.3390/molecules26041155].